Literature DB >> 2296623

Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus.

P Whitton1, G Curzon.   

Abstract

1-(3-Chlorophenyl) piperazine (mCPP) was previously shown to have an anxiogenic-like effect, i.e., it decreased total interaction in a rat social interaction test. Evidence indicated mediation by activation of 5-HT1C receptors with an ED50 of approximately 500 micrograms/kg IP (Kennett et al. 1989). A comparable effect is now shown on infusing 4 micrograms of the drug ICV or infusing 0.5 microgram into the hippocampus. Both responses were dose dependent. Infusion of 1 microgram mCPP into the amygdala had no effect. None of the above treatments significantly reduced locomotion. Results are consistent with the postulated role of the hippocampus in anxiety.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296623     DOI: 10.1007/bf02245806

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

Review 1.  Functional correlates of serotonin 5-HT1 recognition sites.

Authors:  D Hoyer
Journal:  J Recept Res       Date:  1988

2.  Behavior and anxiety: physiologic mechanisms.

Authors:  M Lader
Journal:  J Clin Psychiatry       Date:  1983-11       Impact factor: 4.384

3.  Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.

Authors:  D S Charney; S W Woods; W K Goodman; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.

Authors:  E A Mueller; D L Murphy; T Sunderland
Journal:  J Clin Endocrinol Metab       Date:  1985-12       Impact factor: 5.958

5.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

Authors:  A Pazos; J M Palacios
Journal:  Brain Res       Date:  1985-11-04       Impact factor: 3.252

6.  Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines.

Authors:  J N Crawley
Journal:  Pharmacol Biochem Behav       Date:  1981-11       Impact factor: 3.533

7.  Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia.

Authors:  P H Hutson; T P Donohoe; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors.

Authors:  A Pazos; A Probst; J M Palacios
Journal:  Neuroscience       Date:  1987-04       Impact factor: 3.590

9.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  Neuroanatomical site of the inhibitory influence of anxiolytic drugs on central serotonergic transmission.

Authors:  T Nishikawa; B Scatton
Journal:  Brain Res       Date:  1986-04-16       Impact factor: 3.252

View more
  19 in total

1.  Involvement of 5-HT1B receptors in the anticonflict effect of m-CPP in rats.

Authors:  E Chojnacka-Wójcik; A Kłodzińska
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection.

Authors:  G A Higgins; B J Jones; N R Oakley
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

Authors:  G A Kennett; F Bailey; D C Piper; T P Blackburn
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 4.  5HT drugs in animal models of anxiety.

Authors:  S L Handley; J W McBlane
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 5.  5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.

Authors:  J E Barrett; K E Vanover
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Mono N-aryl ethylenediamine and piperazine derivatives are GABAA receptor blockers: implications for psychiatry.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1993-07       Impact factor: 3.996

7.  5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model.

Authors:  G A Kennett
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.

Authors:  G A Kennett; M D Wood; F Bright; J Cilia; D C Piper; T Gager; D Thomas; G S Baxter; I T Forbes; P Ham; T P Blackburn
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

Review 9.  The serotonergic system and anxiety.

Authors:  Joshua A Gordon; Rene Hen
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

10.  Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.

Authors:  A J Kennedy; E L Gibson; M T O'Connell; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.